PMID- 27530086 OWN - NLM STAT- MEDLINE DCOM- 20171211 LR - 20181202 IS - 1440-1843 (Electronic) IS - 1323-7799 (Linking) VI - 22 IP - 1 DP - 2017 Jan TI - Gas exchange responses during 6-min walk test in patients with pulmonary arterial hypertension. PG - 165-171 LID - 10.1111/resp.12868 [doi] AB - BACKGROUND AND OBJECTIVE: The 6-min walk test (6MWT) is the most widely utilized method of assessing exercise capacity in pulmonary arterial hypertension (PAH). Cardiopulmonary exercise testing has the advantage of providing additional physiological information over 6MWT. The goals of our study were to describe the addition of gas exchange measurements to 6MWT and to determine how these parameters were related to the severity of PAH in three major subgroups of PAH (idiopathic (IPAH), connective tissue disease-related (CTPAH) and congenital heart disease-related (CHPAH)). METHODS: Seventy-six PAH patients (IPAH, n = 28; CTPAH, n = 24; CHPAH, n = 24) completed the 6MWT with simultaneous gas exchange measurements. The 6-min walk distance (6MWD), oxygen uptake ( V O(2) ), carbon dioxide production ( V CO(2) ), oxygen saturation, minute ventilation to carbon dioxide output ( V (E) / V CO(2) ) and end-tidal partial pressure for carbon dioxide (P(ET) CO(2) ) were compared between subgroups, different functional classes (FCs) and pharmacotherapy. RESULTS: Whilst no significant difference in 6MWT was observed, absolute V O(2) and V CO(2) were higher for IPAH (P < 0.05). Differences were removed when V O(2) and V CO(2) were expressed relative to body mass (i.e. mL/kg/min). CHPAH had the most significant desaturation during 6MWT (CPAH: 73 +/- 15%; CTPAH: 90 +/- 8%, IPAH: 92 +/- 8%, P < 0.01). There was no difference in V (E) / V CO(2) and P(ET) CO(2) between groups; however, New York Health Association (NYHA) FC II performed better than FC III subjects in 6MWT with lower V (E) / V CO(2) and higher end-exercise P(ET) CO(2) . Similarly, individuals on more advanced pharmacotherapy (triple therapy vs monotherapy) had poorer gas exchange during exercise. CONCLUSION: Whilst 6MWT and gas exchange did not differentiate between PAH groups, individuals with more severe disease and on more advanced pharmacotherapy had poorer gas exchange during exercise. CI - (c) 2016 Asian Pacific Society of Respirology. FAU - Morris, Norman R AU - Morris NR AD - School of Allied Health Sciences, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia. AD - Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, Queensland, Australia. FAU - Seale, Helen AU - Seale H AD - Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, Queensland, Australia. FAU - Harris, Julie AU - Harris J AD - Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, Queensland, Australia. FAU - Hall, Kathleen AU - Hall K AD - Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, Queensland, Australia. FAU - Lin, Aaron C W AU - Lin AC AD - School of Allied Health Sciences, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia. FAU - Kermeen, Fiona AU - Kermeen F AD - Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, Queensland, Australia. LA - eng PT - Journal Article DEP - 20160816 PL - Australia TA - Respirology JT - Respirology (Carlton, Vic.) JID - 9616368 SB - IM MH - Adult MH - Aged MH - Connective Tissue Diseases/*complications MH - Exercise Tolerance MH - *Familial Primary Pulmonary Hypertension/diagnosis/etiology/physiopathology MH - Female MH - Heart Defects, Congenital/*complications MH - Humans MH - Male MH - Middle Aged MH - Pulmonary Circulation MH - *Pulmonary Gas Exchange MH - Respiratory Function Tests/methods MH - Severity of Illness Index MH - Statistics as Topic MH - Walk Test/*methods OTO - NOTNLM OT - 6-min walk test OT - disease severity OT - exercise and pulmonary rehabilitation OT - gas exchange OT - pulmonary circulation EDAT- 2016/08/18 06:00 MHDA- 2017/12/12 06:00 CRDT- 2016/08/18 06:00 PHST- 2015/12/09 00:00 [received] PHST- 2016/05/26 00:00 [revised] PHST- 2016/06/06 00:00 [accepted] PHST- 2016/08/18 06:00 [pubmed] PHST- 2017/12/12 06:00 [medline] PHST- 2016/08/18 06:00 [entrez] AID - 10.1111/resp.12868 [doi] PST - ppublish SO - Respirology. 2017 Jan;22(1):165-171. doi: 10.1111/resp.12868. Epub 2016 Aug 16.